The hormone, 1,25-dihydroxyvitamin D3 (1,25-[OH]2-D3), inhibits lymphocyte activation in vitro. We studied the ability of the vitamin D metabolite to interfere in vivo with a primary T cell-mediated model of autoimmunity, murine experimental autoimmune encephalomyelitis (EAE). Within 2 wk of antigenic challenge, immunized animals will develop acute paralysis with central nervous tissue inflammation. If mice survive, a rise in antibody titer develops within a month. The administration of 0.1 microgram 1,25-(OH)2-D3 i.p. given every other day for 15 d, starting 3 d before immunization, significantly prevented the development of EAE. The rise in antibody titer to myelin basic protein was also abrogated. Histopathologic lesions of EAE were inhibited by treatment with the sterol. These results suggest a potent immunosuppressive role for 1,25-(OH)2-D3 in vivo in the modulation of a cell-mediated model of autoimmunity.
J M Lemire, D C Archer
Title and authors | Publication | Year |
---|---|---|
Role of Cytochromes P450 in Intestinal Barrier Function: Possible Involvement in the Pathogenesis of Leaky Gut Syndrome.
Makaro A, Kasprzak Z, Jaczynska M, Swierczynski M, Salaga M |
Digestive diseases and sciences | 2025 |
Vitamin D and Neurodegenerative Diseases Such as Multiple Sclerosis (MS), Parkinson’s Disease (PD), Alzheimer’s Disease (AD), and Amyotrophic Lateral Sclerosis (ALS): A Review of Current Literature
Savran Z, Baltaci SB, Aladag T, Mogulkoc R, Baltaci AK |
Current Nutrition Reports | 2025 |
Impact of calcitriol and PGD(2)-G-loaded lipid nanocapsules on oligodendrocyte progenitor cell differentiation and remyelination.
Mwema A, Gratpain V, Ucakar B, Vanvarenberg K, Perdaens O, van Pesch V, Muccioli GG, des Rieux A |
Drug Delivery and Translational Research | 2024 |
Tremendous Fidelity of Vitamin D3 in Age-related Neurological Disorders.
Skv M, Abraham SM, Eshwari O, Golla K, Jhelum P, Maity S, Komal P |
Molecular Neurobiology | 2024 |
Vitamin D receptor gene BsmI (rs1544410) polymorphism: role in multiple sclerosis and genotype-phenotype correlations.
Jamoussi M, Alaya F, Jamoussi H, Baraket G, Achouri A, Mahmoud MB, Fray S, Ben Ali N, Messaoud T, Hannachi Salhi A, Fredj M |
Molecular Biology Reports | 2024 |
Gut microbiota in multiple sclerosis and animal models
Schumacher SM, Doyle WJ, Hill K, Ochoa-Repáraz J |
The FEBS journal | 2024 |
Vitamin D Receptor Polymorphisms Among the Turkish Population are Associated with Multiple Sclerosis.
Bulan B, Hoscan AY, Keskin SN, Cavus A, Culcu EA, Isik N, List EO, Arman A |
2023 | |
Clinical and Imaging Outcomes after Vitamin D Supplementation in Patients with Multiple Sclerosis: A Systematic Review.
Langlois J, Denimal D |
Nutrients | 2023 |
Under the influence: environmental factors as modulators of neuroinflammation through the IL-10/IL-10R axis.
Bugbee E, Wang AA, Gommerman JL |
Frontiers in immunology | 2023 |
Emerging imaging and liquid biomarkers in multiple sclerosis
Gill AJ, Schorr EM, Gadani SP, Calabresi PA |
European Journal of Immunology | 2023 |
In Vivo and In Vitro Evidence for an Interplay between the Glucocorticoid Receptor and the Vitamin D Receptor Signaling.
Bagnoud M, Remlinger J, Massy M, Lodygin D, Salmen A, Chan A, Lühder F, Hoepner R |
Cells | 2023 |
Full spectrum of vitamin D immunomodulation in multiple sclerosis: mechanisms and therapeutic implications.
Galoppin M, Kari S, Soldati S, Pal A, Rival M, Engelhardt B, Astier A, Thouvenot E |
2022 | |
An Update on the Effects of Vitamin D on the Immune System and Autoimmune Diseases.
Sîrbe C, Rednic S, Grama A, Pop TL |
International journal of molecular sciences | 2022 |
Is there a window of opportunity for the therapeutic use of vitamin D in multiple sclerosis?
Zorzella-Pezavento SFG, Mimura LAN, Denadai MB, de Souza WDF, Fraga-Silva TFC, Sartori A |
Neural Regeneration Research | 2022 |
Vitamin D as a Risk Factor for Multiple Sclerosis: Immunoregulatory or Neuroprotective?
Gombash SE, Lee PW, Sawdai E, Lovett-Racke AE |
Frontiers in neurology | 2022 |
Improving Glucocorticoid Sensitivity of Brain-Homing CD4+ T Helper Cells by Steroid Hormone Crosstalk.
Koetzier SC, van Langelaar J, Wierenga-Wolf AF, Melief MJ, Pol K, Musters S, Lubberts E, Dik WA, Smolders J, van Luijn MM |
Frontiers in immunology | 2022 |
Vitamin D and immuno-pathology of COVID-19: many interactions but uncertain therapeutic benefits
A Banerjee, U Ganguly, S Saha, S Chakrabarti, RV Saini, RK Rawal, L Saso, S Chakrabarti |
Expert Review of Anti-infective Therapy | 2021 |
Nutritional and ecological perspectives of the interrelationships between diet and the gut microbiome in multiple sclerosis: Insights from marmosets
ME Perez-Muñoz, S Sugden, HJ Harmsen, BA t Hart, JD Laman, J Walter |
iScience | 2021 |
New Epidermal-Growth-Factor-Related Insights Into the Pathogenesis of Multiple Sclerosis: Is It Also Epistemology?
Scalabrino G |
Frontiers in neurology | 2021 |
Preclinical Therapy with Vitamin D3 in Experimental Encephalomyelitis: Efficacy and Comparison with Paricalcitol
LA Mimura, TF de Campos Fraga-Silva, LR de Oliveira, LL Ishikawa, PA Borim, C de Moraes Machado, J de Anchieta de Castro e Horta Júnior, DM da Fonseca, A Sartori |
International journal of molecular sciences | 2021 |
Vitamin D Deficiency, Osteoporosis and Effect on Autoimmune Diseases and Hematopoiesis: A Review
MD Martinis, A Allegra, MM Sirufo, A Tonacci, G Pioggia, M Raggiunti, L Ginaldi, S Gangemi |
International journal of molecular sciences | 2021 |
Rays of immunity: Role of sunshine vitamin in management of COVID-19 infection and associated comorbidities
VU kumar, G Pavan, K Murti, R Kumar, S Dhingra, M Haque, V Ravichandiran |
Clinical Nutrition ESPEN | 2021 |
Vitamin D can be effective on the prevention of COVID-19 complications: A narrative review on molecular aspects
AA Shiravi, M Saadatkish, Z Abdollahi, P Miar, H Khanahmad, M Zeinalian |
International journal for vitamin and nutrition research. Internationale Zeitschrift für Vitamin- und Ernährungsforschung. Journal international de vitaminologie et de nutrition | 2020 |
Micronutrients in autoimmune diseases: possible therapeutic benefits of zinc and vitamin D
I Wessels, L Rink |
The Journal of Nutritional Biochemistry | 2020 |
Neuron-Specific Vitamin D Signaling Attenuates Microglia Activation and CNS Autoimmunity
PW Lee, A Selhorst, SG Lampe, Y Liu, Y Yang, AE Lovett-Racke |
Frontiers in neurology | 2020 |
Multiple Sclerosis
Lane M, Yadav V |
Textbook of Natural Medicine | 2020 |
Inflammation, HIV, and Immune Quiescence: Leveraging on Immunomodulatory Products to Reduce HIV Susceptibility.
Cromarty R, Archary D |
AIDS Research and Treatment | 2020 |
Role of diet in regulating the gut microbiota and multiple sclerosis
JM Sanchez, AB DePaula-Silva, JE Libbey, RS Fujinami |
Clinical Immunology | 2020 |
The Influence of Vitamin D on Neurodegeneration and Neurological Disorders: A Rationale for its Physio-pathological Actions
M Morello, M Pieri, R Zenobi, A Talamo, D Stephan, V Landel, F Féron, P Millet |
Current pharmaceutical design | 2020 |
Vitamin D and Genetic Susceptibility to Multiple Sclerosis
C Scazzone, L Agnello, G Bivona, BL Sasso, M Ciaccio |
Biochemical Genetics | 2020 |
High-Dose Vitamin D-Mediated Hypercalcemia as a Potential Risk Factor in Central Nervous System Demyelinating Disease
D Häusler, S Torke, MS Weber |
Frontiers in immunology | 2020 |
Calcitriol Prevents Neuroinflammation and Reduces Blood-Brain Barrier Disruption and Local Macrophage/Microglia Activation
LR de Oliveira, LA Mimura, TF de Campos Fraga-Silva, LL Ishikawa, AA Fernandes, SF Zorzella-Pezavento, A Sartori |
Frontiers in pharmacology | 2020 |
Can Brain Health Be Supported by Vitamin D-Based Supplements? A Critical Review
M Farghali, S Ruga, V Morsanuto, F Uberti |
Brain Sciences | 2020 |
Drugs for Multiple Sclerosis Activate Natural Killer Cells: Do They Protect Against COVID-19 Infection? M Al-Ani, NM Elemam, JE Hundt, AA Maghazachi |
Infection and drug resistance | 2020 |
Vitamin D as a Potential Therapy for Multiple Sclerosis: Where Are We?
S Wasnik, I Sharma, DJ Baylink, X Tang |
International journal of molecular sciences | 2020 |
Vitamin D and Disease Severity in Multiple Sclerosis—Baseline Data From the Randomized Controlled Trial (EVIDIMS)
P Bäcker-Koduah, J Bellmann-Strobl, M Scheel, J Wuerfel, KD Wernecke, J Dörr, AU Brandt, F Paul |
Frontiers in neurology | 2020 |
Failed, Interrupted, or Inconclusive Trials on Immunomodulatory Treatment Strategies in Multiple Sclerosis: Update 2015–2020
L Rolfes, M Pawlitzki, S Pfeuffer, N Huntemann, H Wiendl, T Ruck, SG Meuth |
BioDrugs | 2020 |
Vitamin D as a Principal Factor in Mediating Rheumatoid Arthritis-Derived Immune Response
MM Aslam, P John, A Bhatti, S Jahangir, MI Kamboh |
BioMed Research International | 2019 |
Aligning the Paradoxical Role of Vitamin D in Gastrointestinal Immunity
MT Cantorna, CJ Rogers, J Arora |
Trends in endocrinology and metabolism: TEM | 2019 |
High dose vitamin D exacerbates central nervous system autoimmunity by raising T-cell excitatory calcium
D Häusler, S Torke, E Peelen, T Bertsch, M Djukic, R Nau, C Larochelle, SS Zamvil, W Brück, MS Weber |
Brain | 2019 |
Vitamin D Supplementation in Central Nervous System Demyelinating Disease—Enough Is Enough
D Häusler, M Weber |
International journal of molecular sciences | 2019 |
Human Memory Th17 Cell Populations Change Into Anti-inflammatory Cells With Regulatory Capacity Upon Exposure to Active Vitamin D
W Dankers, N Davelaar, JP van Hamburg, J van de Peppel, EM Colin, E Lubberts |
Frontiers in immunology | 2019 |
Analysis of vitamin D-binding protein (VDBP) gene polymorphisms in Korean women with and without endometriosis
MC Cho, JH Kim, MH Jung, IA Cho, HC Jo, JK Shin, SA Lee, WJ Choi, JH Lee |
Clinical and Experimental Reproductive Medicine | 2019 |
Multiple Sclerosis and Vitamin D – Caviar or a Dog’s Dinner?
C Hawkes, G Giovannoni, J Lechner-Scott, M Levy, E Waubant |
Multiple Sclerosis and Related Disorders | 2019 |
Sağlıklı Çocuklarla, Dil ve Konuşma Bozukluğu Olan Çocuklar Arasında Vitamin D Düzeyinin Karşılaştırılması
S EROĞLU |
2019 | |
Clinical Neuroimmunology: Multiple Sclerosis and Related Disorders
SA Rizvi, JF Cahill, PK Coyle |
2019 | |
An Update on Vitamin D and Disease Activity in Multiple Sclerosis
J Smolders, Ø Torkildsen, W Camu, T Holmøy |
CNS Drugs | 2019 |
Vitamin D as a Potential Agent for Ischemic Axonal Regeneration after Epineurial Devascularization of the Sciatic Nerve
H Erdem, L Sarikcioglu, N Boyan, O Oguz |
Current neurovascular research | 2019 |
Prevention and treatment of experimental autoimmune encephalomyelitis induced mice with 1, 25-dihydroxyvitamin D 3
D Haghmorad, E Yazdanpanah, MJ Tavaf, S Zargarani, A Soltanmohammadi, MB Mahmoudi, M Mahmoudi |
Neurological Research | 2019 |
Vitamin D and Multiple Sclerosis: An Open-Ended Story
C Scazzone, L Agnello, BL Sasso, AM Ciaccio, RV Giglio, G Bivona, M Ciaccio |
The open biochemistry journal | 2019 |
Vitamin D increases remyelination by promoting oligodendrocyte lineage differentiation
U GomezPinedo, JA Cuevas, MS BenitoMartín, L MorenoJiménez, N EstebanGarcia, L TorreFuentes, JA MatíasGuiu, V Pytel, P Montero, J MatíasGuiu |
Brain and Behavior | 2019 |
Evolving Role of Vitamin D in Immune-Mediated Disease and Its Implications in Autoimmune Hepatitis
AJ Czaja, AJ Montano-Loza |
Digestive Diseases and Sciences | 2018 |
Vitamin D: Nutrient, Hormone, and Immunomodulator
F Sassi, C Tamone, P DAmelio |
Nutrients | 2018 |
Interrelation of Diet, Gut Microbiome, and Autoantibody Production
I Petta, J Fraussen, V Somers, M Kleinewietfeld |
Frontiers in immunology | 2018 |
Sex-Specific Gene-by-Vitamin D Interactions Regulate Susceptibility to Central Nervous System Autoimmunity
DN Krementsov, L Asarian, Q Fang, MM McGill, C Teuscher |
Frontiers in immunology | 2018 |
Vitamin D and remyelination in multiple sclerosis
J Matías-Guíu, C Oreja-Guevara, JA Matias-Guiu, U Gomez-Pinedo |
Neurología (English Edition) | 2018 |
Vitamin D down-regulates the expression of some Th17 cell-related cytokines, key inflammatory chemokines, and chemokine receptors in experimental autoimmune encephalomyelitis
A Jafarzadeh, SV Azizi, Z Arabi, R Ahangar-Parvin, M Mohammadi-Kordkhayli, T Larussa, F Khatami, M Nemati |
Nutritional Neuroscience | 2018 |
Skin-derived TSLP systemically expands regulatory T cells
TM Leichner, A Satake, VS Harrison, Y Tanaka, AS Archambault, BS Kim, MC Siracusa, WJ Leonard, A Naji, GF Wu, D Artis, T Kambayashi |
Journal of Autoimmunity | 2017 |
Crosstalk between sphingolipids and vitamin D3: potential role in the nervous system: Crosstalk between sphingolipids and vitamin D3
M Garcia-Gil, F Pierucci, A Vestri, E Meacci |
British Journal of Pharmacology | 2017 |
Vitamin D in Autoimmunity: Molecular Mechanisms and Therapeutic Potential
W Dankers, EM Colin, JP van Hamburg, E Lubberts |
Frontiers in immunology | 2017 |
Metabolomics: A potential way to know the role of vitamin D on multiple sclerosis
D Luque-Córdoba, MD de Castro |
Journal of Pharmaceutical and Biomedical Analysis | 2017 |
A Critical Evaluation of Vitamin D - Clinical Overview
S Gowder |
A Critical Evaluation of Vitamin D - Clinical Overview | 2017 |
Modulation of Multiple Sclerosis and Its Animal Model Experimental Autoimmune Encephalomyelitis by Food and Gut Microbiota
WJ van Hoogen, JD Laman, BA Hart |
Frontiers in immunology | 2017 |
Vitamin D in the prevention, prediction and treatment of neurodegenerative and neuroinflammatory diseases
P Koduah, F Paul, JM Dörr |
The EPMA Journal | 2017 |
UVB radiation, vitamin D and multiple sclerosis
HF DeLuca, L Plum |
Photochemical & Photobiological Sciences | 2017 |
Nutrition et sclérose en plaques : le point de la littérature
P Fayemendy, JC Desport, J Cornu, O Ragi, P Jésus |
Nutrition Clinique et Métabolisme | 2017 |
Vitamin D and the brain: Genomic and non-genomic actions
X Cui, H Gooch, A Petty, JJ McGrath, D Eyles |
Molecular and Cellular Endocrinology | 2017 |
Active form of vitamin D directly protects the blood-brain barrier in multiple sclerosis
S Takahashi, T Maeda, Y Sano, H Nishihara, Y Takeshita, F Shimizu, T Kanda |
Clinical and Experimental Neuroimmunology | 2017 |
Vitamin D and plasma cell dyscrasias: reviewing the significance
N Burwick |
Annals of Hematology | 2017 |
Effect of vitamin D replacement on immunological biomarkers in patients with multiple sclerosis
MF Mrad, NK el Ayoubi, MO Esmerian, JM Kazan, SJ Khoury |
Clinical Immunology | 2017 |
Metabolites: deciphering the molecular language between DCs and their environment
L Minarrieta, P Ghorbani, T Sparwasser, L Berod |
Seminars in Immunopathology | 2016 |
Vitamina D y remielinización en la esclerosis múltiple
J Matías-Guíu, C Oreja-Guevara, JA Matias-Guiu, U Gomez-Pinedo |
Neurología | 2016 |
Vitamin D and the Pathogenesis of Inflammatory Bowel Disease
BN Limketkai, ML Bechtold, DL Nguyen |
Current Gastroenterology Reports | 2016 |
Immune Rebalancing
P Ilaria, LS Francesca, M Paola |
Immune Rebalancing | 2016 |
Effect of vitamin D supplementation on inflammation: protocol for a systematic review
A Mousa, M Misso, H Teede, R Scragg, B Courten |
BMJ Open | 2016 |
Association of myelin peptide with vitamin D prevents autoimmune encephalomyelitis development
LA Mimura, F Chiuso-Minicucci, TF Fraga-Silva, SF Zorzella-Pezavento, TG França, LL Ishikawa, M Penitenti, MR Ikoma, A Sartori |
Neuroscience | 2016 |
Systematic Review of Pharmacological Properties of the Oligodendrocyte Lineage
C Marinelli, T Bertalot, M Zusso, SD Skaper, P Giusti |
Frontiers in cellular neuroscience | 2016 |
Low 25-hydroxyvitamin D levels are associated with vitiligo: a systematic review and meta-analysis
S Upala, A Sanguankeo |
Photodermatology, Photoimmunology & Photomedicine | 2016 |
Mesenchymal Stromal/Stem Cells Do Not Ameliorate Experimental Autoimmune Encephalomyelitis and Are Not Detectable in the Central Nervous System of Transplanted Mice
P Abramowski, S Krasemann, T Ernst, C Lange, H Ittrich, M Schweizer, AR Zander, R Martin, B Fehse |
Stem Cells and Development | 2016 |
Predisposing role of vitamin D receptor (VDR) polymorphisms in the development of multiple sclerosis: A case-control study
R Abdollahzadeh, MS Fard, F Rahmani, K Moloudi, BS kalani, A Azarnezhad |
Journal of the Neurological Sciences | 2016 |
The absence of 25-hydroxyvitamin D3-1α-hydroxylase potentiates the suppression of EAE in mice by ultraviolet light
Y Wang, SJ Marling, VM Martino, JM Prahl, HF Deluca |
The Journal of Steroid Biochemistry and Molecular Biology | 2016 |
A Novel Combination of Docosahexaenoic Acid, All-Trans Retinoic Acid, and 1, 25-Dihydroxyvitamin D3 Reduces T-Bet Gene Expression, Serum Interferon Gamma, and Clinical Scores but Promotes PPARγ Gene Expression in Experimental Autoimmune Encephalomyelitis
MR Shiri-Shahsavar, A Mirshafiee, K Parastouei, A Ebrahimi-Kalan, S Yekaninejad, F Soleymani, R Chahardoli, RM Fard, AA Saboor-Yaraghi |
Journal of Molecular Neuroscience | 2016 |
Vitamin D receptor gene polymorphisms/haplotypes and serum 25(OH)D3 levels in Hashimoto’s thyroiditis
S Giovinazzo, TM Vicchio, R Certo, A Alibrandi, O Palmieri, A Campennì, S Cannavò, F Trimarchi, RM Ruggeri |
Endocrine | 2016 |
Vitamin D and cognition
H Wehr, M Bednarska-Makaruk |
Postępy Psychiatrii i Neurologii | 2016 |
Translational Neuroimmunology in Multiple Sclerosis
M Trojano, C Avolio |
Translational Neuroimmunology in Multiple Sclerosis | 2016 |
The role of the solar and geomagnetic activity in the etiology of multiple sclerosis: a review of the literature and prospects of research
ID Stolyarov, ZA Goncharova, GG Shkilnyuk, NA Samoylova |
ZH NEVROL PSIKHIATR | 2016 |
Environmental Factors and Their Regulation of Immunity in Multiple Sclerosis
Trojano M, Avolio C |
Translational Neuroimmunology in Multiple Sclerosis | 2016 |
Vitamin D Deficiency and Hashimoto’s Thyroiditis in Children and Adolescents: a Critical Vitamin D Level for This Association?
O Evliyaoğlu, M Acar, B Özcabı, E Erginöz, F Bucak, O Ercan, M Kucur |
Journal of clinical research in pediatric endocrinology | 2015 |
1,25-Dihydroxyvitamin D3 enhances neural stem cell proliferation and oligodendrocyte differentiation
HA Shirazi, J Rasouli, B Ciric, A Rostami, GX Zhang |
Experimental and Molecular Pathology | 2015 |
Mechanisms Underlying the Regulation of Innate and Adaptive Immunity by Vitamin D
R Wei, S Christakos |
Nutrients | 2015 |
Vitamin D3 and Monomethyl Fumarate Enhance Natural Killer Cell Lysis of Dendritic Cells and Ameliorate the Clinical Score in Mice Suffering from Experimental Autoimmune Encephalomyelitis
Z Al-Jaderi, A Maghazachi |
Toxins | 2015 |
Multiple sclerosis and environmental factors: the role of vitamin D, parasites, and Epstein-Barr virus infection
J Correale, MI Gaitán |
Acta Neurologica Scandinavica | 2015 |
Suppression of murine experimental autoimmune encephalomyelitis development by 1,25-dihydroxyvitamin D3 with autophagy modulation
C Zhen, X Feng, Z Li, Y Wang, B Li, L Li, M Quan, G Wang, L Guo |
Journal of Neuroimmunology | 2015 |
Evidence for the Importance of Vitamin D Status in Neurologic Conditions
AK Yeshokumar, D Saylor, MD Kornberg, EM Mowry |
Current Treatment Options in Neurology | 2015 |
1,25-Dihydroxyvitamin D3-Conditioned CD11c+ Dendritic Cells are Effective Initiators of CNS Autoimmune Disease
D Besusso, L Saul, MD Leech, RA OConnor, AS MacDonald, SM Anderton, RJ Mellanby |
Frontiers in immunology | 2015 |
Peripheral blood biomarkers in multiple sclerosis
A D'Ambrosio, S Pontecorvo, T Colasanti, S Zamboni, A Francia, P Margutti |
Autoimmunity Reviews | 2015 |
Multiple Sklerose
M Krumbholz, E Meinl |
Multiple Sklerose | 2015 |
Vitamin D receptor–retinoid X receptor heterodimer signaling regulates oligodendrocyte progenitor cell differentiation
AG de la Fuente, O Errea, P Wijngaarden, GA Gonzalez, C Kerninon, AA Jarjour, HJ Lewis, CA Jones, B Nait-Oumesmar, C Zhao, JK Huang, C ffrench-Constant, RJ Franklin |
The Journal of Cell Biology | 2015 |
1,25-Dihydroxyvitamin D3 Protects against Immune-Mediated Killing of Neurons in Culture and in Experimental Autoimmune Encephalomyelitis
S Sloka, S Zhornitsky, C Silva, LM Metz, VW Yong, S Nataf |
PloS one | 2015 |
Multiple sclerosis patients have a diminished serologic response to vitamin D supplementation compared to healthy controls
P Bhargava, SU Steele, E Waubant, NR Revirajan, J Marcus, M Dembele, SD Cassard, BW Hollis, C Crainiceanu, EM Mowry |
Multiple sclerosis (Houndmills, Basingstoke, England) | 2015 |
“Disease modifying nutricals” for multiple sclerosis
K Schmitz, J Barthelmes, L Stolz, S Beyer, O Diehl, I Tegeder |
Pharmacology & Therapeutics | 2014 |
Role of vitamin D3 in treatment of lumbar disc herniation--pain and sensory aspects: study protocol for a randomized controlled trial
Mahsa Sedighi, Ali Haghnegahdar |
2014 | |
Vitamin D as a Potential Therapy in Amyotrophic Lateral Sclerosis
A Gianforcaro, MJ Hamadeh |
CNS Neuroscience & Therapeutics | 2014 |
Vitamin D Therapy in Experimental Allergic Encephalomyelitis Could be Limited by Opposing Effects of Sphingosine 1-Phosphate and Gelsolin Dysregulation
Y Zhu, Z Qin, J Gao, M Yang, Y Qin, T Shen, S Liu |
Molecular Neurobiology | 2014 |
Vitamin D levels in Indian systemic lupus erythematosus patients: association with disease activity index and interferon alpha
M Mandal, R Tripathy, AK Panda, SS Pattanaik, S Dakua, A Pradhan, S Chakraborty, B Ravindran, BK Das |
Arthritis Research & Therapy | 2014 |
Comparison of Antioxidant Status and Vitamin D Levels between Multiple Sclerosis Patients and Healthy Matched Subjects
E Hejazi, R Amani, N SharafodinZadeh, B Cheraghian |
Multiple Sclerosis International | 2014 |
25-Hydroxyvitamin D Levels and Acute Cellular Rejection in Liver Transplant Patients
M Sheikh-Ali, AP Keaveny, A Chamseddin, L Aguirre, B Clarke, S Meek |
Endocrine Practice | 2014 |
Microbial view of central nervous system autoimmunity
K Berer, G Krishnamoorthy |
FEBS Letters | 2014 |
Vitamin D Improves Cognitive Function and Modulates Th17/Treg Cell Balance After Hepatectomy in Mice
A Tian, H Ma, X Cao, R Zhang, X Wang, B Wu |
Inflammation | 2014 |
Vitamin D receptor agonists’ anti-inflammatory properties: VDR agonists’ anti-inflammatory properties
J Vojinovic |
Annals of the New York Academy of Sciences | 2014 |
Multiple sclerosis and the role of immune cells
Rune A Høglund, Azzam A Maghazachi |
World Journal of Experimental Medicine | 2014 |
Vitamin D3 metabolite calcidiol primes human dendritic cells to promote the development of immunomodulatory IL-10-producing T cells
G Bakdash, TM van Capel, LM Mason, ML Kapsenberg, EC de Jong |
Vaccine | 2014 |
Seasonal variation of relapse rate in multiple sclerosis is latitude dependent: Variation of MS Relapses
T Spelman, O Gray, M Trojano, T Petersen, G Izquierdo, A Lugaresi, R Hupperts, R Bergamaschi, P Duquette, P Grammond, G Giuliani, C Boz, F Verheul, C Oreja-Guevara, M Barnett, F Grand'Maison, ME Rio, J Lechner-Scott, VV Pesch, RF Bolanos, S Flechter, LD Braber-Moerland, G Iuliano, MP Amato, M Slee, E Cristiano, ML Saladino, M Paine, N Vella, K Kasa, N Deri, J Herbert, F Moore, T Petkovska-Boskova, R Alroughani, A Savino, C Shaw, S Vucic, V Santiago, EA Bacile, E Skromne, D Poehlau, JA Cabrera-Gomez, R Lucas, H Butzkueven |
Annals of Neurology | 2014 |
Targeted 25-hydroxyvitamin D3 1α-hydroxylase Adoptive Gene Therapy Ameliorates DSS-induced Colitis Without Causing Hypercalcemia in Mice
B Li, DJ Baylink, MH Walter, KH Lau, X Meng, J Wang, A Cherkas, X Tang, X Qin |
Molecular Therapy | 2014 |
Low Levels of Vitamin D in Neuromyelitis Optica Spectrum Disorder: Association with Disease Disability
JH Min, P Waters, A Vincent, HJ Cho, BE Joo, SY Woo, SY Lee, HY Shin, KH Lee, BJ Kim, M Bradl |
PloS one | 2014 |
La vitamine D au secours du traumatisme médullaire : un espoir à confirmer
F Féron, T Marqueste, J Bianco, Y Gueye, JF Chabas, P Decherchi |
Biologie Aujourd hui | 2014 |
Rôles bénéfiques de la vitamine D sur la neurodégénérescence et les troubles mentaux
P Millet, V Landel, I Virard, M Morello, F Féron |
Cahiers de Nutrition et de Diététique | 2014 |
Role of vitamin D3 in Treatment of Lumbar Disc Herniation—Pain and Sensory Aspects: Study Protocol for a Randomized Controlled Trial
M Sedighi, A Haghnegahdar |
Trials | 2014 |
Vitamin D and Crohn’s Disease in the Adult Patient: A Review
A Basson |
JPEN. Journal of parenteral and enteral nutrition | 2014 |
Higher weight in adolescence and young adulthood is associated with an earlier age at multiple sclerosis onset
KS Kavak, BE Teter, J Hagemeier, K Zakalik, B Weinstock-Guttman, K Edwards, A Goodman, M Gottesman, J Herbert, I Kister, B Jubelt, P Coyle, L Krupp, M Lenihan, A Gerber, A Perel, R Zivadinov, C Granger |
Multiple sclerosis (Houndmills, Basingstoke, England) | 2014 |
1,25-Dihydroxyvitamin D3 selectively and reversibly impairs T helper-cell CNS localization
IV Grishkan, AN Fairchild, PA Calabresi, AR Gocke |
Proceedings of the National Academy of Sciences | 2013 |
The neuropathology of obesity: insights from human disease
EB Lee, MP Mattson |
Acta Neuropathologica | 2013 |
Vitamin D Biology Revealed Through the Study of Knockout and Transgenic Mouse Models
S Christakos, T Seth, J Hirsch, A Porta, A Moulas, P Dhawan |
Annual Review of Nutrition | 2013 |
Can we prevent or treat multiple sclerosis by individualised vitamin D supply?
J Dörr, A Döring, F Paul |
The EPMA Journal | 2013 |
Serum levels of 25-hydroxy vitamin D in normal Biozzi and C57BL/6 mice and during the course of chronic relapsing experimental autoimmune encephalomyelitis (CR EAE)
C Bolton, J Gates, G Giovannoni |
Inflammation Research | 2013 |
Suppression of experimental autoimmune encephalomyelitis by 300–315nm ultraviolet light
Y Wang, SJ Marling, SM McKnight, AL Danielson, KS Severson, HF Deluca |
Archives of Biochemistry and Biophysics | 2013 |
Dietary vitamin D deficiency in rats from middle to old age leads to elevated tyrosine nitration and proteomics changes in levels of key proteins in brain: Implications for low vitamin D-dependent age-related cognitive decline
JT Keeney, S Förster, R Sultana, LD Brewer, CS Latimer, J Cai, JB Klein, NM Porter, DA Butterfield |
Free radical biology & medicine | 2013 |
Sex-specific environmental influences affecting MS development
J Correale, ME Aguirre, MF Farez |
Clinical Immunology | 2013 |
Textbook of Natural Medicine
JA Bralley, RS Lord |
Textbook of Natural Medicine | 2013 |
The influence of vitamin D supplementation on melatonin status in patients with multiple sclerosis
D Golan, E Staun-Ram, L Glass-Marmor, I Lavi, O Rozenberg, S Dishon, M Barak, S Ish-Shalom, A Miller |
Brain, Behavior, and Immunity | 2013 |
Review: The role of vitamin D in nervous system health and disease: Vitamin D and the brain
GC DeLuca, SM Kimball, J Kolasinski, SV Ramagopalan, GC Ebers |
Neuropathology and Applied Neurobiology | 2013 |
Efficacy of vitamin D in treating multiple sclerosis-like neuroinflammation depends on developmental stage
MZ Adzemovic, M Zeitelhofer, S Hochmeister, SA Gustafsson, M Jagodic |
Experimental Neurology | 2013 |
Effects of Vitamin D3, Calcipotriol and FTY720 on the Expression of Surface Molecules and Cytolytic Activities of Human Natural Killer Cells and Dendritic Cells
Z Al-Jaderi, A Maghazachi |
Toxins | 2013 |
Intradermal application of vitamin D3 increases migration of CD14+ dermal dendritic cells and promotes the development of Foxp3+ regulatory T cells
G Bakdash, LP Schneider, TM van Capel, ML Kapsenberg, MB Teunissen, EC de Jong |
Human Vaccines & Immunotherapeutics | 2013 |
Intradermal application of vitamin D3 increases migration of CD14 (+) dermal dendritic cells and promotes the development of Foxp3 (+) regulatory T cells
G Bakdash, LP Schneider, TM van Capel, ML Kapsenberg, MB Teunissen, EC de Jong |
Human Vaccines & Immunotherapeutics | 2013 |
Environmental factors acting during development to influence MS risk: insights from animal studies
DN Krementsov, C Teuscher |
Multiple sclerosis (Houndmills, Basingstoke, England) | 2013 |
Environmental factors and their regulation of immunity in multiple sclerosis
MW Koch, LM Metz, SM Agrawal, VW Yong |
Journal of the Neurological Sciences | 2013 |
The Ifng Gene Is Essential for Vdr Gene Expression and Vitamin D 3 -Mediated Reduction of the Pathogenic T Cell Burden in the Central Nervous System in Experimental Autoimmune Encephalomyelitis, a Multiple Sclerosis Model
JA Spanier, FE Nashold, JK Olson, CE Hayes |
Journal of immunology (Baltimore, Md. : 1950) | 2012 |
Efficacy of Vitamin D Supplementation in Multiple Sclerosis (EVIDIMS Trial): study protocol for a randomized controlled trial
J Dörr, S Ohlraun, H Skarabis, F Paul |
Trials | 2012 |
Pathogenesis of multiple sclerosis via environmental and genetic dysregulation of N-glycosylation
A Grigorian, H Mkhikian, CF Li, BL Newton, RW Zhou, M Demetriou |
Seminars in Immunopathology | 2012 |
Vitamin D deficiency affects the immunity against Mycobacterium tuberculosis infection in mice
H Yang, Z Zhang, Z Chang, K Tang, D Lin, J Xu |
Clinical and Experimental Medicine | 2012 |
Multiple Sclerosis: New Insights in Pathogenesis and Novel Therapeutics
D Ontaneda, M Hyland, JA Cohen |
Annual Review of Medicine | 2012 |
Development of experimental autoimmune encephalomyelitis (EAE) in mice requires vitamin D and the vitamin D receptor
Y Wang, SJ Marling, JG Zhu, KS Severson, HF DeLuca |
Proceedings of the National Academy of Sciences | 2012 |
Epidemiology and Genetics
PL de Jager |
Multiple Sclerosis Diagnosis and Therapy | 2012 |
Extraskeletal Effects of Vitamin D
H Wolden-Kirk, C Gysemans, A Verstuyf, C Mathieu |
Endocrinology and metabolism clinics of North America | 2012 |
Effects of ultraviolet light on human serum 25-hydroxyvitamin D and systemic immune function
SV Milliken, H Wassall, BJ Lewis, J Logie, RN Barker, H Macdonald, MA Vickers, AD Ormerod |
Journal of Allergy and Clinical Immunology | 2012 |
Vitamin D und Multiple Sklerose: Der Stellenwert für das Erkrankungsrisiko und die Behandlung
A Döring, F Paul, J Dörr |
Der Nervenarzt | 2012 |
The nervous system's potential role in multiple sclerosis associated bone loss
S Josyula, BK Mehta, Y Karmon, B Teter, S Batista, J Ostroff, B Weinstock-Guttman |
Journal of the Neurological Sciences | 2012 |
Hazai konszenzus a D-vitamin szerepéről a betegségek megelőzésében és kezelésében
I Takács, I Benkő, E Toldy, N Wikonkál, L Szekeres, E Bodolay, E Kiss, Z Jambrik, B Szabó, B Merkely, Z Valkusz, T Kovács, A Szabó, O Grigoreff, Z Nagy, J Demeter, HC Horváth, N Bittner, S Várbíró, P Lakatos |
Orvosi Hetilap | 2012 |
Fat-soluble vitamins as disease modulators in multiple sclerosis
Ø Torkildsen, KI Løken-Amsrud, S Wergeland, KM Myhr, T Holmøy |
Acta Neurologica Scandinavica | 2012 |
Role of Vitamin D in the Onset, Progression and Severity of Multiple Sclerosis
S Mesliniene, L Ramrattan, S Giddings, M Sheikh-Ali |
Endocrine Practice | 2012 |
Oxidative Stress and Disease: Oxidative Stress, Immunity, and Aging
P Singh, M Campbell |
Oxidative Stress and Disease | 2012 |
Cerebrospinal fluid proteome comparison between multiple sclerosis patients and controls
AC Kroksveen, A Guldbrandsen, C Vedeler, KM Myhr, JA Opsahl, FS Berven |
Acta Neurologica Scandinavica | 2012 |
1,25-Dihyroxyvitamin D3 promotes FOXP3 expression via binding to vitamin D response elements in its conserved noncoding sequence region
SW Kang, SH Kim, N Lee, WW Lee, KA Hwang, MS Shin, SH Lee, WU Kim, I Kang |
Journal of immunology (Baltimore, Md. : 1950) | 2012 |
Contribution of vitamin D insufficiency to the pathogenesis of multiple sclerosis
C Pierrot-Deseilligny, JC Souberbielle |
Therapeutic advances in neurological disorders | 2012 |
Vitamin D Responsive Elements within the HLA-DRB1 Promoter Region in Sardinian Multiple Sclerosis Associated Alleles
E Cocco, A Meloni, MR Murru, D Corongiu, S Tranquilli, E Fadda, R Murru, L Schirru, MA Secci, G Costa, I Asunis, S Cuccu, G Fenu, L Lorefice, N Carboni, G Mura, MC Rosatelli, MG Marrosu, M Campbell |
PloS one | 2012 |
1,25-Dihyroxyvitamin D 3 Promotes FOXP3 Expression via Binding to Vitamin D Response Elements in Its Conserved Noncoding Sequence Region
SW Kang, SH Kim, N Lee, WW Lee, KA Hwang, MS Shin, SH Lee, WU Kim, I Kang |
Journal of immunology (Baltimore, Md. : 1950) | 2012 |
The beneficial role of vitamin D in systemic lupus erythematosus (SLE)
K vinh quốc Lương, LT Nguyễn |
Clinical Rheumatology | 2012 |
Vitamin D, Multiple Sclerosis and Inflammatory Bowel Disease
MT Cantorna |
Archives of Biochemistry and Biophysics | 2011 |
Impact of Vitamin D in the Treatment of Tuberculosis
K Luong, LT Nguyen |
The American Journal of the Medical Sciences | 2011 |
Genetics and the environment converge to dysregulate N-glycosylation in multiple sclerosis
H Mkhikian, A Grigorian, CF Li, HL Chen, B Newton, RW Zhou, C Beeton, S Torossian, GG Tatarian, SU Lee, K Lau, E Walker, KA Siminovitch, KG Chandy, Z Yu, JW Dennis, M Demetriou |
Nature Communications | 2011 |
Predominance of Th2 polarization by vitamin D through a STAT6-dependent mechanism
S Sloka, C Silva, J Wang, VW Yong |
Journal of Neuroinflammation | 2011 |
Vitamin D receptor (VDR) gene SNPs influence VDR expression and modulate protection from multiple sclerosis in HLA-DRB1*15-positive individuals
C Agliardi, FR Guerini, M Saresella, D Caputo, MA Leone, M Zanzottera, E Bolognesi, I Marventano, N Barizzone, ME Fasano, N Al-Daghri, M Clerici |
Brain, Behavior, and Immunity | 2011 |
Assessment of evidence for a protective role of vitamin D in multiple sclerosis
HE Hanwell, B Banwell |
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease | 2011 |
Vitamin D in the healthy and inflamed central nervous system
J Smolders, SM Moen, J Damoiseaux, I Huitinga, T Holmøy |
Journal of the Neurological Sciences | 2011 |
Therapeutic Effect of Vitamin D3 in Multiple Sclerosis Patients
G Mosayebi, A Ghazavi, K Ghasami, Y Jand, P Kokhaei |
Immunological Investigations | 2011 |
Individual and Joint Action of Environmental Factors and Risk of MS
IA der Mei, S Simpson, J Stankovich, BV Taylor |
Neurologic Clinics | 2011 |
Environmental Factors in Multiple Sclerosis: Epstein-Barr Virus, Vitamin D, and Cigarette Smoking
DM Wingerchuk |
Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine | 2011 |
Vitamin D deficiency diminishes the severity and delays onset of experimental autoimmune encephalomyelitis
HF DeLuca, LA Plum |
Archives of Biochemistry and Biophysics | 2011 |
Efficacy and mechanisms of action of vitamin D in experimental polyarthritis
M Moghaddami, G Mayrhofer, PH Anderson, HA Morris, MV der Hoek, LG Cleland |
Immunology and Cell Biology | 2011 |
Vitamin D and multiple sclerosis: can vitamin D prevent disease progression?
B Mehta, M Ramanathan, B Weinstock-Guttman |
Expert Review of Neurotherapeutics | 2011 |
Vitamin D-mediated immune regulation in Multiple Sclerosis
J Correale, MC Ysrraelit, MI Gaitán |
Journal of the Neurological Sciences | 2011 |
Sun Exposure, Vitamin D Intake and Progression to Disability among Veterans with Progressive Multiple Sclerosis
TY McDowell, S Amr, WJ Culpepper, P Langenberg, W Royal, C Bever, DD Bradham |
Neuroepidemiology | 2011 |
Seasonal, gestational and postnatal influences on multiple sclerosis: The beneficial role of a vitamin D supplementation during early life
DA de Abreu, V Landel, F Féron |
Journal of the Neurological Sciences | 2011 |
Does Vitamin D Affect Risk of Developing Autoimmune Disease?: A Systematic Review
MA Kriegel, JA Manson, KH Costenbader |
Seminars in Arthritis and Rheumatism | 2011 |
Minireview: Vitamin D: Is There a Role in Extraskeletal Health?
S Christakos, HF DeLuca |
Endocrinology | 2011 |
Polymorphisms in the vitamin D receptor gene and multiple sclerosis risk: A meta-analysis of case–control studies
J Huang, ZF Xie |
Journal of the Neurological Sciences | 2011 |
Vitamine D et auto-immunité. Deuxième partie : aspects cliniques
Y Schoindre, B Terrier, JE Kahn, D Saadoun, JC Souberbielle, O Benveniste, Z Amoura, JC Piette, P Cacoub, N Costedoat-Chalumeau |
La Revue de Médecine Interne | 2011 |
Vitamin D and the immune system: Getting it right
C Mathieu |
IBMS BoneKEy | 2011 |
Vitamin D and Multiple Sclerosis
CE Hayes, FE Nashold, CG Mayne, JA Spanier, CD Nelson |
Vitamin D | 2011 |
Control of Adaptive Immunity by Vitamin D Receptor Agonists
L Adorini |
Vitamin D | 2011 |
XVI European Charcot Foundation lecture: nutrition and environment: can MS be prevented?
KC Simon, KL Munger, A Ascherio |
Journal of the Neurological Sciences | 2011 |
Vitamin D and multiple sclerosis: Potential pathophysiological role and clinical implications
SJ Dudani, S Kalhan, SP Sharma |
International journal of applied & basic medical research | 2011 |
Regulation of Mycobacterium-Specific Mononuclear Cell Responses by 25-Hydroxyvitamin D3
CD Nelson, BJ Nonnecke, TA Reinhardt, WR Waters, DC Beitz, JD Lippolis, JH Fritz |
PloS one | 2011 |
1,25-Dihydroxyvitamin D3 Ameliorates Th17 Autoimmunity via Transcriptional Modulation of Interleukin-17A
S Joshi, LC Pantalena, XK Liu, SL Gaffen, H Liu, C Rohowsky-Kochan, K Ichiyama, A Yoshimura, L Steinman, S Christakos, S Youssef |
Molecular and cellular biology | 2011 |
Clinical Neuroimmunology
SA Rizvi, PK Coyle |
2011 | |
Therapeutic approaches to multiple sclerosis: an update on failed, interrupted, or inconclusive trials of neuroprotective and alternative treatment strategies
SG Meuth, S Bittner, JC Ulzheimer, C Kleinschnitz, BC Kieseier, H Wiendl |
BioDrugs | 2010 |
Therapeutic approaches to multiple sclerosis: an update on failed, interrupted, or inconclusive trials of neuroprotective and alternative treatment strategies
SG Meuth, S Bittner, JC Ulzheimer, C Kleinschnitz, BC Kieseier, H Wiendl |
BioDrugs | 2010 |
The essential role of Epstein-Barr virus in the pathogenesis of multiple sclerosis
MP Pender |
The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry | 2010 |
Lineage-specific Effects of 1,25-Dihydroxyvitamin D3 on the Development of Effector CD4 T Cells*
MT Palmer, YK Lee, CL Maynard, JR Oliver, DD Bikle, AM Jetten, CT Weaver |
The Journal of biological chemistry | 2010 |
Vitamin D, disease and therapeutic opportunities
LA Plum, HF DeLuca |
Nature Reviews Drug Discovery | 2010 |
Vitamin D and multiple sclerosis
A Ascherio, KL Munger, KC Simon |
The Lancet Neurology | 2010 |
The expanding spectrum of biological actions of vitamin D
J Rojas-Rivera, CD la Piedra, A Ramos, A Ortiz, J Egido |
Nephrology Dialysis Transplantation | 2010 |
Is hypovitaminosis D one of the environmental risk factors for multiple sclerosis?
C Pierrot-Deseilligny, JC Souberbielle |
Brain | 2010 |
Fall prevention and vitamin D in the elderly: an overview of the key role of the non-bone effects
C Annweiler, M Montero-Odasso, AM Schott, G Berrut, B Fantino, O Beauchet |
Journal of neuroengineering and rehabilitation | 2010 |
Complementary and alternative medicine for the treatment of multiple sclerosis
V Yadav, L Shinto, D Bourdette |
Expert Review of Clinical Immunology | 2010 |
UV radiation suppresses experimental autoimmune encephalomyelitis independent of vitamin D production
BR Becklund, KS Severson, SV Vang, HF DeLuca |
Proceedings of the National Academy of Sciences | 2010 |
The impact of vitamin D on dendritic cell function in patients with systemic lupus erythematosus
I Ben-Zvi, C Aranow, M Mackay, A Stanevsky, DL Kamen, LM Marinescu, CE Collins, GS Gilkeson, B Diamond, JA Hardin |
PloS one | 2010 |
Role of vitamin D in immune responses and autoimmune diseases, with emphasis on its role in multiple sclerosis
HL Zhang, J Wu |
Neuroscience Bulletin | 2010 |
Multiple Sclerosis and Vitamin D: A Review and Recommendations
AJ Solomon, RH Whitham |
Current Neurology and Neuroscience Reports | 2010 |
Very low levels of vitamin D in systemic sclerosis patients
P Caramaschi, AD Gassa, O Ruzzenente, A Volpe, V Ravagnani, I Tinazzi, G Barausse, LM Bambara, D Biasi |
Clinical Rheumatology | 2010 |
1α,25-Dihydroxyvitamin D3 and all-trans retinoic acid synergistically inhibit the differentiation and expansion of Th17 cells
U Ikeda, D Wakita, T Ohkuri, K Chamoto, H Kitamura, Y Iwakura, T Nishimura |
Immunology Letters | 2010 |
The beneficial role of vitamin D and its analogs in cancer treatment and prevention
K Luong, LT Nguyen |
Critical Reviews in Oncology/Hematology | 2010 |
Vitamin D and multiple sclerosis: what are the guidelines for a reliable clinical trial?
F Féron |
Expert Review of Neurotherapeutics | 2010 |
Season of birth and multiple sclerosis in Sweden
J Salzer, A Svenningsson, P Sundström |
Acta Neurologica Scandinavica | 2010 |
New hypotheses on sunlight and the geographic variability of multiple sclerosis prevalence
BK Mehta |
Journal of the Neurological Sciences | 2010 |
Vitamins & Hormones
KJ Hare, FK Knop |
Vitamins & Hormones | 2010 |
The Effect of Vitamin D3 Alone and Mixed With IFN-γ on Tachyzoites of Toxoplasma gondii (RH Strain) Proliferation and Nitric Oxide (NO) Production in Infected Macrophages of BALB/C Mice
F Ghaffarifar, MA Pour, Z Sharifi, AD Asl, E Al-Kawaz |
Iranian Journal of Parasitology | 2010 |
Blue Books of Neurology
H Wiendl, N Melzer, C Kleinschnitz, SG Meuth |
Blue Books of Neurology | 2010 |
Vitamin D and Multiple Sclerosis:
E Stevens |
Topics in clinical nutrition | 2010 |
Les effets extra-osseux de la vitamine D : faits, questions et controverses
B Bouvard, C Annveiller, A Sallé, O Beauchet, D Chappard, M Audran, E Legrand |
Revue du Rhumatisme | 2010 |
Lineage-specific Effects of 1,25-Dihydroxyvitamin D 3 on the Development of Effector CD4 T Cells
MT Palmer, YK Lee, CL Maynard, JR Oliver, DD Bikle, AM Jetten, CT Weaver |
The Journal of biological chemistry | 2010 |
Regulation of calcium signaling in dendritic cells by 1,25-dihydroxyvitamin D 3
E Shumilina, NT Xuan, N Matzner, M Bhandaru, IM Zemtsova, F Lang |
The FASEB Journal | 2010 |
Gender Differences in 1,25 Dihydroxyvitamin D 3 Immunomodulatory Effects in Multiple Sclerosis Patients and Healthy Subjects
J Correale, MC Ysrraelit, MI Gaitán |
Journal of immunology (Baltimore, Md. : 1950) | 2010 |
Enhancement of 1,25-dihydroxyvitamin D3-mediated suppression of experimental autoimmune encephalomyelitis by calcitonin
BR Becklund, DW Hansen, HF Deluca |
Proceedings of the National Academy of Sciences | 2009 |
Combination treatment with progesterone and vitamin D hormone may be more effective than monotherapy for nervous system injury and disease
M Cekic, I Sayeed, DG Stein |
Frontiers in Neuroendocrinology | 2009 |
Epidemiology of Multiple Sclerosis: Environmental Factors
Ascherio A, Munger KL |
Blue Books of Neurology | 2009 |
Body size and risk of MS in two cohorts of US women
KL Munger, T Chitnis, A Ascherio |
Neurology | 2009 |
Impact on allergic immune response after treatment with vitamin A
V Matheu, K Berggård, Y Barrios, Y Barrios, MR Arnau, JM Zubeldia, ML Baeza, O Back, S Issazadeh-Navikas |
Nutrition & Metabolism | 2009 |
Clinical implications of a possible role of vitamin D in multiple sclerosis
C Pierrot-Deseilligny |
Journal of Neurology | 2009 |
Paricalcitol reduces basal and lipopolysaccharide-induced (LPS) TNF-α and IL-8 production by human peripheral blood mononuclear cells
T Eleftheriadis, G Antoniadi, V Liakopoulos, C Kartsios, I Stefanidis, G Galaktidou |
International Urology and Nephrology | 2009 |
Vitamin-regulated cytokines and growth factors in the CNS and elsewhere
G Scalabrino |
Journal of Neurochemistry | 2009 |
Long-term trends in the incidence of type 1 diabetes in Denmark: the seasonal variation changes over time
J Svensson, A Lyngaae-Jørgensen, B Carstensen, LB Simonsen, HB Mortensen |
Pediatric Diabetes | 2009 |
Multiple sclerosis: clinical features, pathophysiology, neuroimaging and future therapies
AP Borazanci, MK Harris, RN Schwendimann, E Gonzalez-Toledo, AH Maghzi, M Etemadifar, N Alekseeva, J Pinkston, RE Kelley, A Minagar |
Future Neurology | 2009 |
Immunomodulatory effects of Vitamin D in multiple sclerosis
J Correale, MC Ysrraelit, MI Gaitan |
Brain | 2009 |
Gender differences in multiple sclerosis: Cytokines and vitamin D
MJ Eikelenboom, J Killestein, JJ Kragt, BM Uitdehaag, CH Polman |
Journal of the Neurological Sciences | 2009 |
Vitamin D, a neuro-immunomodulator: Implications for neurodegenerative and autoimmune diseases
DA de Abreu, D Eyles, F Féron |
Psychoneuroendocrinology | 2009 |
A salmon based diet protects mice from behavioural changes in the cuprizone model for demyelination
Ø Torkildsen, LA Brunborg, AM Milde, SJ Mørk, KM Myhr, L Bø |
Clinical Nutrition | 2009 |
The calcitonin/calcitonin gene related peptide-α gene is not required for 1α,25-dihydroxyvitamin D3-mediated suppression of experimental autoimmune encephalomyelitis
BR Becklund, BJ James, RF Gagel, HF DeLuca |
Archives of Biochemistry and Biophysics | 2009 |
Higher levels of 25-hydroxyvitamin D are associated with a lower incidence of multiple sclerosis only in women
JJ Kragt, BM Amerongen, J Killestein, CD Dijkstra, BM Uitdehaag, CH Polman, P Lips |
Multiple sclerosis (Houndmills, Basingstoke, England) | 2009 |
Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20.
|
Nature Genetics | 2009 |
Vitamin D and Human Health: Lessons from Vitamin D Receptor Null Mice
R Bouillon, G Carmeliet, L Verlinden, E van Etten, A Verstuyf, HF Luderer, L Lieben, C Mathieu, M Demay |
Endocrine reviews | 2008 |
Vitamin effects on the immune system: vitamins A and D take centre stage
JR Mora, M Iwata, UH von Andrian |
Nature Reviews Immunology | 2008 |
Vitamin D deficiency modulates Graves' hyperthyroidism induced in BALB/c mice by thyrotropin receptor immunization
A Misharin, M Hewison, CR Chen, V Lagishetty, HA Aliesky, Y Mizutori, B Rapoport, SM McLachlan |
Endocrinology | 2008 |
The paradoxical effects of vitamin D on type 1 mediated immunity
MT Cantorna, S Yu, D Bruce |
Molecular Aspects of Medicine | 2008 |
Vitamin D in systemic lupus erythematosus
D Kamen, C Aranow |
Current Opinion in Rheumatology | 2008 |
Vitamin D analogs: Therapeutic applications and mechanisms for selectivity
AJ Brown, E Slatopolsky |
Molecular Aspects of Medicine | 2008 |
Novel therapeutic strategies for multiple sclerosis — a multifaceted adversary
RS Lopez-Diego, HL Weiner |
Nature Reviews Drug Discovery | 2008 |
Vitamin D and multiple sclerosis
A Raghuwanshi, SS Joshi, S Christakos |
Journal of Cellular Biochemistry | 2008 |
Vitamin D as an immune modulator in multiple sclerosis, a review
J Smolders, J Damoiseaux, P Menheere, R Hupperts |
Journal of Neuroimmunology | 2008 |
Vitamin D2Potentiates Axon Regeneration
JF Chabas, O Alluin, G Rao, S Garcia, MN Lavaut, JJ Risso, R Legre, G Magalon, M Khrestchatisky, T Marqueste, P Decherchi, F Feron |
Journal of Neurotrauma | 2008 |
Vitamin D and rheumatoid arthritis: is there a link?
G KIRAN, D DEBASHISH |
International Journal of Rheumatic Diseases | 2008 |
Examining the evidence: complementary adjunctive therapies for multiple sclerosis
M Namaka, A Crook, A Doupe, K Kler, M Vasconcelos, M Klowak, Y Gong, A Wojewnik-Smith, M Melanson |
Neurological Research | 2008 |
Principles of Bone Biology
CJ Rosen, T Niu |
Principles of Bone Biology | 2008 |
Vitamin D signaling in immune-mediated disorders: Evolving insights and therapeutic opportunities
F Baeke, E Etten, C Gysemans, L Overbergh, C Mathieu |
Molecular Aspects of Medicine | 2008 |
Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis
J Smolders, P Menheere, A Kessels, J Damoiseaux, R Hupperts |
Multiple sclerosis (Houndmills, Basingstoke, England) | 2008 |
Vitamin D and autoimmunity: new aetiological and therapeutic considerations
Y Arnson, H Amital, Y Shoenfeld |
Annals of the rheumatic diseases | 2007 |
Vitamin D receptor signaling contributes to susceptibility to infection with Leishmania major
J Ehrchen, L Helming, G Varga, B Pasche, K Loser, M Gunzer, C Sunderkötter, C Sorg, J Roth, A Lengeling |
The FASEB Journal | 2007 |
Vitamin D Receptor Agonists in the Treatment of Autoimmune Diseases: Selective Targeting of Myeloid but Not Plasmacytoid Dendritic Cells
G Penna, S Amuchastegui, G Laverny, L Adorini |
Journal of Bone and Mineral Research | 2007 |
Association of the vitamin D metabolism gene CYP27B1 with type 1 diabetes
R Bailey, JD Cooper, L Zeitels, DJ Smyth, JH Yang, NM Walker, E Hyppönen, DB Dunger, E Ramos-Lopez, K Badenhoop, S Nejentsev, JA Todd |
Diabetes | 2007 |
Novel insights in the immune function of the vitamin D system: Synergism with interferon-beta
E Etten, C Gysemans, DD Branisteanu, A Verstuyf, R Bouillon, L Overbergh, C Mathieu |
The Journal of Steroid Biochemistry and Molecular Biology | 2007 |
Vitamin D levels in people with multiple sclerosis and community controls in Tasmania, Australia
IA Mei, AL Ponsonby, T Dwyer, L Blizzard, BV Taylor, T Kilpatrick, H Butzkueven, AJ McMichael |
Journal of Neurology | 2007 |
Risk factors in the development of multiple sclerosis
KL Munger, A Ascherio |
Expert Review of Clinical Immunology | 2007 |
Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors
A Ascherio, KL Munger |
Annals of Neurology | 2007 |
Control of T Cell-mediated Autoimmunity by Metabolite Flux to N -Glycan Biosynthesis
A Grigorian, SU Lee, W Tian, IJ Chen, G Gao, R Mendelsohn, JW Dennis, M Demetriou |
The Journal of biological chemistry | 2007 |
Safety of vitamin D3 in adults with multiple sclerosis
SM Kimball, MR Ursell, P O'Connor, R Vieth |
The American journal of clinical nutrition | 2007 |
The Biology of Dendritic Cells and HIV Infection
S Gessani, F Belardelli |
2007 | |
1,25-Dihydroxyvitamin D3 inhibits lipopolysaccharide-induced immune activation in human endothelial cells
O Equils, Y Naiki, AM Shapiro, K Michelsen, D Lu, J Adams, S Jordan |
Clinical & Experimental Immunology | 2006 |
Interaction among vitamin D3 analogue KH 1060, TNF-α, and vitamin D receptor protein in peripheral blood mononuclear cells of inflammatory bowel disease patients
M Stio, M Martinesi, S Bruni, C Treves, G d'Albasio, S Bagnoli, AG Bonanomi |
International Immunopharmacology | 2006 |
IL-10 Signaling Is Essential for 1,25-Dihydroxyvitamin D 3 -Mediated Inhibition of Experimental Autoimmune Encephalomyelitis
KM Spach, FE Nashold, BN Dittel, CE Hayes |
Journal of immunology (Baltimore, Md. : 1950) | 2006 |
Hypercalcemia produced by parathyroid hormone suppresses experimental autoimmune encephalomyelitis in female but not male mice
TF Meehan, J Vanhooke, J Prahl, HF DeLuca |
Archives of Biochemistry and Biophysics | 2005 |
Vitamin D3 confers protection from autoimmune encephalomyelitis only in female mice
KM Spach, CE Hayes |
Journal of immunology (Baltimore, Md. : 1950) | 2005 |
22-ene-25-oxa-vitamin D: a new vitamin D analogue with profound immunosuppressive capacities
C Daniel, T Schlauch, U Zugel, A Steinmeyer, HH Radeke, D Steinhilber, J Stein |
European Journal of Clinical Investigation | 2005 |
The role of vitamin D in protecting type 1 diabetes mellitus
K Luong, LT Nguyen, DN Nguyen |
Diabetes/Metabolism Research and Reviews | 2005 |
Immunomodulating effects of vitamin D analogs in hemodialysis patients
E Seibert, NW Levin, MK Kuhlmann |
Hemodialysis International | 2005 |
Immunoregulation by 1,25-dihydroxyvitamin D3: Basic concepts
E Etten, C Mathieu |
The Journal of Steroid Biochemistry and Molecular Biology | 2005 |
Intervention in autoimmunity: The potential of vitamin D receptor agonists
L Adorini |
Cellular Immunology | 2005 |
Calcium and 1?,25-dihydroxyvitamin?D3 target the TNF-? pathway to suppress experimental inflammatory bowel disease
Y Zhu, BD Mahon, M Froicu, MT Cantorna |
European Journal of Immunology | 2005 |
Vitamin D Receptor Polymorphisms are Associated with Graves' Disease in German and Polish But not in Serbian Patients
E Ramos-Lopez, A Kurylowicz, T Bednarczuk, J Paunkovic, C Seidl, K Badenhoop |
Thyroid | 2005 |
Mucosal Immunology
WR Brown |
Mucosal Immunology | 2005 |
Heterogeneity of vitamin D receptor gene association with celiac disease and type 1 diabetes mellitus
JI Pedro, JR Bilbao, GP de Nanclares, JC Vitoria, P Martul, L Castaño |
Autoimmunity | 2005 |
Treatment with 1, 25-Dihydroxyvitamin D3 Preserves Glomerular Slit Diaphragm-Associated Protein Expression in Experimental Glomerulonephritis
M Migliori, L Giovannini, V Panichi, C Filippi, D Taccola, N Origlia, C Mannari, G Camussi |
International journal of immunopathology and pharmacology | 2005 |
25-Hydroxyvitamin D levels in serum at the onset of multiple sclerosis
M Soilu-Hänninen, L Airas, I Mononen, A Heikkilä, M Viljanen, A Hänninen |
Multiple sclerosis (Houndmills, Basingstoke, England) | 2005 |
Transcriptional Profiling of γδ T Cells Identifies a Role for Vitamin D in the Immunoregulation of the Vγ9Vδ2 Response to Phosphate-Containing Ligands
L Chen, MT Cencioni, DF Angelini, G Borsellino, L Battistini, CF Brosnan |
Journal of immunology (Baltimore, Md. : 1950) | 2005 |
Micronutrients and the Risk of Type 1 Diabetes: Vitamin D, Vitamin E, and Nicotinamide
E Hypponen |
Nutrition Reviews | 2004 |
Prediabetes: prediction and prevention trials
F Vendrame, PA Gottlieb |
Endocrinology & Metabolism Clinics of North America | 2004 |
CYP27B1 polymorphisms variants are associated with type 1 diabetes mellitus in Germans
ER Lopez, K Regulla, MA Pani, M Krause, KH Usadel, K Badenhoop |
The Journal of Steroid Biochemistry and Molecular Biology | 2004 |
Immunoendocrinology in Health and Disease
N Martens, E Hooghe-Peters, R Hooghe |
Immunoendocrinology in Health and Disease | 2004 |
Gene expression analysis suggests that 1,25-dihydroxyvitamin D 3 reverses experimental autoimmune encephalomyelitis by stimulating inflammatory cell apoptosis
KM Spach, LB Pedersen, FE Nashold, T Kayo, BS Yandell, TA Prolla, CE Hayes |
Physiological genomics | 2004 |
Multiple sclerosis and vitamin D: an update
BM VanAmerongen, CD Dijkstra, P Lips, CH Polman |
European Journal of Clinical Nutrition | 2004 |
Effect of Anti-TNF Therapy and Vitamin D Derivatives on the Proliferation of Peripheral Blood Mononuclear Cells in Crohn's Disease
M Stio, C Treves, M Martinesi, G d'Albasio, S Bagnoli, AG Bonanomi |
Digestive Diseases and Sciences | 2004 |
VITAMINDAND ITSANALOGS ASREGULATORS OFIMMUNEACTIVATION ANDANTIGENPRESENTATION
MD Griffin, N Xing, R Kumar |
Annual Review of Nutrition | 2003 |
The pleiotropic actions of vitamin D
R Lin, JH White |
BioEssays | 2003 |
New insights into the mechanisms of vitamin D action
S Christakos, P Dhawan, Y Liu, X Peng, A Porta |
Journal of Cellular Biochemistry | 2003 |
Treatment of experimental autoimmune encephalomyelitis in rat by 1,25-dihydroxyvitamin D3 leads to early effects within the central nervous system
E Garcion, L Sindji, S Nataf, P Brachet, F Darcy, CN Montero-Menei |
Acta Neuropathologica | 2003 |
Role of Hypolipidemic Drug Clofibrate in Altering Iron Regulatory Proteins IRP1 and IRP2 Activities and Hepatic Iron Metabolism in Rats Fed a Low-Iron Diet
HL Huang, NS Shaw |
Toxicology and Applied Pharmacology | 2002 |
CD8(+) T cells are not necessary for 1 alpha,25-dihydroxyvitamin D(3) to suppress experimental autoimmune encephalomyelitis in mice
TF Meehan, HF DeLuca |
Proceedings of the National Academy of Sciences | 2002 |
A Novel Immunosuppressive 1alpha,25-Dihydroxyvitamin D3 Analog with Reduced Hypercalcemic Activity
U Zugel, A Steinmeyer, C Giesen, K Asadullah |
Journal of Investigative Dermatology | 2002 |
The coming of age of 1,25-dihydroxyvitamin D3 analogs as immunomodulatory agents
C Mathieu, L Adorini |
Trends in Molecular Medicine | 2002 |
New clues about vitamin D functions in the nervous system
E Garcion, N Wion-Barbot, CN Montero-Menei, F Berger, D Wion |
Trends in Endocrinology & Metabolism | 2002 |
Retinoic acid promotes the development of Th2-like human myelin basic protein-reactive T cells
AE Lovett-Racke, MK Racke |
Cellular Immunology | 2002 |
Immunomodulatory effects of vitamin D receptor ligands in autoimmune diseases
L Adorini |
International Immunopharmacology | 2002 |
The vitamin D receptor is necessary for 1α,25-dihydroxyvitamin D3 to suppress experimental autoimmune encephalomyelitis in mice
TF Meehan, HF DeLuca |
Archives of Biochemistry and Biophysics | 2002 |
A 1 ,25-Dihydroxyvitamin D3 Analog Enhances Regulatory T-Cells and Arrests Autoimmune Diabetes in NOD Mice
S Gregori, N Giarratana, S Smiroldo, M Uskokovic, L Adorini |
Diabetes | 2002 |
Effects of 1α,25(OH) 2 D 3 and its analogs on dendritic cell function: 1α,25(OH) 2 D 3 and Dendritic Cells
MD Griffin, R Kumar |
Journal of Cellular Biochemistry | 2002 |
Vitamin D and autoimmune diabetes: Vitamin D and Autoimmune Diabetes
JB Zella, HF DeLuca |
Journal of Cellular Biochemistry | 2002 |
Association of vitamin D receptor gene BsmI polymorphisms in Chinese patients with systemic lupus erythematosus
CM Huang, MC Wu, JY Wu, FJ Tsai |
Lupus | 2002 |
1,25-Dihydroxyvitamin D 3 Inhibits IFN-γ and IL-4 Levels During In Vitro Polarization of Primary Murine CD4 + T Cells
TP Staeva-Vieira, LP Freedman |
Journal of immunology (Baltimore, Md. : 1950) | 2002 |
Vitamin D3 and Its Synthetic Analogs Inhibit the Spontaneous in Vitro Immunoglobulin Production by SLE-Derived PBMC
M Linker-Israeli, E Elstner, JR Klinenberg, DJ Wallace, HP Koeffler |
Clinical Immunology | 2001 |
Dendritic cell modulation by 1alpha,25 dihydroxyvitamin D3 and its analogs: a vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo
MD Griffin, W Lutz, VA Phan, LA Bachman, DJ McKean, R Kumar |
Proceedings of the National Academy of Sciences | 2001 |
Effects of 1,25(OH)2D3 in experimental mesangial proliferative nephritis in rats
V Panichi, M Migliori, D Taccola, C Filippi, LD Nisco, L Giovannini, R Palla, C Tetta, G Camussi |
Kidney International | 2001 |
Influence of vitamin D receptor gene polymorphisms on mortality risk in hemodialysis patients
MP Marco, L Craver, A Betriu, J Fibla, E Fernández |
American Journal of Kidney Diseases | 2001 |
1α,25-Dihydroxyvitamin D3 Has a Direct Effect on Naive CD4 + T Cells to Enhance the Development of Th2 Cells
A Boonstra, FJ Barrat, C Crain, VL Heath, HF Savelkoul, A OGarra |
Journal of immunology (Baltimore, Md. : 1950) | 2001 |
Influence of cholecalciferol (vitamin D3) on the course of experimental systemic lupus erythematosus in F1 (NZBxW) mice
MW Vaisberg, R Kaneno, MF Franco, NF Mendes |
Journal of Clinical Laboratory Analysis | 2000 |
1,25-Dihydroxyvitamin D3 treatment decreases macrophage accumulation in the CNS of mice with experimental autoimmune encephalomyelitis
FE Nashold, DJ Miller, CE Hayes |
Journal of Neuroimmunology | 2000 |
Potent Inhibition of Dendritic Cell Differentiation and Maturation by Vitamin D Analogs
MD Griffin, WH Lutz, VA Phan, LA Bachman, DJ McKean, R Kumar |
Biochemical and Biophysical Research Communications | 2000 |
Recent developments in the use of vitamin D analogues
A Verstuyf, S Segaert, L Verlinden, R Bouillon, C Mathieu |
Expert Opinion on Investigational Drugs | 2000 |
Rat oligodendrocytes express the vitamin D3 receptor and respond to 1,25-dihydroxyvitamin D3
D Baas, K Pr�fer, ME Ittel, S Kuchler-Bopp, G Labourdette, LL Sarli�ve, P Brachet |
Glia | 2000 |
Vitamin D and Autoimmunity: Is Vitamin D Status an Environmental Factor Affecting Autoimmune Disease Prevalence?
MT Cantorna |
Proceedings of the Society for Experimental Biology and Medicine | 2000 |
Vitamin D: a natural inhibitor of multiple sclerosis
CE Hayes |
Proceedings of the Nutrition Society | 2000 |
Vitamin D receptor gene polymorphism in multiple sclerosis and the association with HLA class II alleles
M Niino, T Fukazawa, I Yabe, S Kikuchi, H Sasaki, K Tashiro |
Journal of the Neurological Sciences | 2000 |
Expression of 1,25-Dihydroxyvitamin D3 Receptor in the Immune System
CM Veldman, MT Cantorna, HF DeLuca |
Archives of Biochemistry and Biophysics | 2000 |
ANALOGS OF 1,25-DIHYDROXYVITAMIN D 3 AS DOSE-REDUCING AGENTS FOR CLASSICAL IMMUNOSUPPRESSANTS12:
E van Etten, DD Branisteanu, A Verstuyf, M Waer, R Bouillon, C Mathieu |
Transplantation | 2000 |
1,25-Dihydroxycholecalciferol Prevents and Ameliorates Symptoms of Experimental Murine Inflammatory Bowel Disease
MT Cantorna, C Munsick, C Bemiss, BD Mahon |
The Journal of nutrition | 2000 |
Neuro-Immune Interactions in Neurologic and Psychiatric Disorders
P Patterson, C Kordon, Y Christen |
2000 | |
1α,25-Dihydroxyvitamin D 3 Inhibits Differentiation, Maturation, Activation, and Survival of Dendritic Cells Leading to Impaired Alloreactive T Cell Activation
G Penna, L Adorini |
Journal of immunology (Baltimore, Md. : 1950) | 2000 |
Influence of cholecalciferol (vitamin D3) on the course of experimental systemic lupus erythematosus in F1 (NZBxW) mice
Vaisberg MW, Kaneno R, Franco MF, Mendes NF |
Journal of Clinical Laboratory Analysis | 2000 |
Autocrine control of vitamin D metabolism in synovial cells from arthritic patients
SJ Smith, ME Hayes, PL Selby, EB Mawer |
Annals of the rheumatic diseases | 1999 |
Association of vitamin D receptor gene polymorphism with multiple sclerosis in Japanese
T Fukazawa, I Yabe, S Kikuchi, H Sasaki, T Hamada, K Miyasaka, K Tashiro |
Journal of the Neurological Sciences | 1999 |
Dietary Calcium Is a Major Factor in 1,25-Dihydroxycholecalciferol Suppression of Experimental Autoimmune Encephalomyelitis in Mice
MT Cantorna, J Humpal-Winter, HF DeLuca |
The Journal of nutrition | 1999 |
Inhibition of IL-12 production by 1,25-dihydroxyvitamin D3. Involvement of NF-kappaB downregulation in transcriptional repression of the p40 gene
D D'Ambrosio, M Cippitelli, MG Cocciolo, D Mazzeo, PD Lucia, R Lang, F Sinigaglia, P Panina-Bordignon |
Journal of Clinical Investigation | 1998 |
A vitamin D analogue (MC 1288) has immunomodulatory properties and suppresses collagen-induced arthritis (CIA) without causing hypercalcaemia
P Larsson, L Mattsson, L Klareskog, C Johnsson |
Clinical & Experimental Immunology | 1998 |
Expression of inducible nitric oxide synthase during rat brain inflammation: Regulation by 1,25-dihydroxyvitamin D3
E Garcion, L Sindji, C Montero-Menei, C Andre, P Brachet, F Darcy |
Glia | 1998 |
Calcitriol modulates in vivo and in vitro cytokine production: A role for intracellular calcium
V Panichi, SD Pietro, B Andreini, AM Bianchi, M Migliori, D Taccola, L Giovannini, C Tetta, R Palla |
Kidney International | 1998 |
Effect of 1,25(OH)2 vitamin D3 on glomerulosclerosis in subtotally nephrectomized rats
U Schwarz, K Amann, SR Orth, A Simonaviciene, S Wessels, E Ritz |
Kidney International | 1998 |
Neuroinflammation
PL Wood |
Neuroinflammation | 1998 |
The effect of 1,25(OH)2 vitamin D3 on subsets of T lymphocytes in postmenopausal women
I Žofková, RL Kancheva |
Life Sciences | 1997 |
1,25-Dihydroxyvitamin D3 inhibits the expression of inducible nitric oxide synthase in rat central nervous system during experimental allergic encephalomyelitis
E Garcion, S Nataf, A Berod, F Darcy, P Brachet |
Brain research. Molecular brain research | 1997 |
A VITAMIN D ANALOG, MC1288, INHIBITS ADVENTITIAL INFLAMMATION AND SUPPRESSES INTIMAL LESIONS IN RAT AORTIC ALLOGRAFTS:
AK Risnen-Sokolowski, IS Pakkala, SP Samila, L Binderup, PJ Hyry, NA Pakkala |
Transplantation | 1997 |
Effect of 1,25-dihydroxyvitamin D3 on mouse thymus: role of extracellular calcium
M Mohamed |
Biochimica et Biophysica Acta (BBA) - General Subjects | 1996 |
Vitamin D Analogues in Insulin-Dependent Diabetes Mellitus and Other Autoimmune Diseases: A Therapeutic Perspective
D Mauricio, T Mandrup-Poulsen, J Nerup |
Diabetes/Metabolism Reviews | 1996 |
1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis
MT Cantorna, CE Hayes, HF DeLuca |
Proceedings of the National Academy of Sciences | 1996 |
Induction of common mucosal immunity by hormonally immunomodulated peripheral immunization
RA Daynes, EY Enioutina, S Butler, HH Mu, ZA McGee, AA B |
Infection and immunity | 1996 |
Experimental allergic encephalomyelitis in the rat is inhibited by aminoguanidine, an inhibitor of nitric oxide synthase
W Zhao, RG Tilton, JA Corbett, ML McDaniel, TP Misko, JR Williamson, AH Cross, WF Hickey |
Journal of Neuroimmunology | 1996 |
Combination of Vitamin D Analogues and Immunosuppressants: Potential Clinical Use
DD Branisteanu, C Mathieu, K Casteels, R Bouillon |
Clinical immunotherapeutics | 1996 |
Immunomodulatory actions of 1,25-Dihydroxyvitamin D3
JM Lemire |
The Journal of Steroid Biochemistry and Molecular Biology | 1995 |
Optimal concentration of tacalcitol in once-daily treatment of psoriasis
O Baadsgaard, J Traulsen, J Roed-Petersen, H Jakobsen |
Journal of Dermatological Treatment | 1995 |
Advances in Drug Research
CL Crespi |
Advances in Drug Research | 1995 |
Non-hypercalcemic pharmacological aspects of vitamin D analogs
R Bouillon, A Verstuyf, L Verlinden, K Allewaert, D Branisteanu, C Mathieu, HV Baelen |
Biochemical Pharmacology | 1995 |
Treating tumor-bearing mice with vitamin D3 diminishes tumor-induced myelopoiesis and associated immunosuppression, and reduces tumor metastasis and recurrence
MR Young, J Ihm, Y Lozano, MA Wright, MM Prechel |
Cancer Immunology, Immunotherapy | 1995 |
Effects of In Vivo Administration of 1,25-Dihydroxyvitamin D3 on In Vitro Proliferation of Bovine Lymphocytes1
FG Hustmyer, DC Beitz, JP Goff, BJ Nonnecke, RL Horst, TA Reinhardt |
Journal of Dairy Science | 1994 |
MC 1288 - A vitamin D analogue with immunosuppressive effects on heart and small bowel grafts
C Johnsson, G Tufveson |
Transplant International | 1994 |
MC 1288 ? A vitamin D analogue with immunosuppressive effects on heart and small bowel grafts
C Johnsson, G Tufveson |
Transplant International | 1994 |
Prevention of autoimmune diabetes in NOD mice by 1,25 dihydroxyvitamin D3
C Mathieu, M Waer, J Laureys, O Rutgeerts, R Bouillon |
Diabetologia | 1994 |
Effects of two new vitamin D3 derivatives, 22-oxa-1α-25-dihydroxyvitamin D3 (OCT) and 2β-(3-hydroxypropoxy)-1α,25-dihydroxyvitamin D3 (ED-71), on bone metabolism in organ culture
K Sato, Y Nishii, FN Woodiel, LG Raisz |
Bone | 1993 |
Partial prevention of active Heymann nephritis by 1 alpha, 25 dihydroxyvitamin D3
DD Branisteanu, P Leenaerts, B Damme, R Bouillon |
Clinical & Experimental Immunology | 1993 |
Partial prevention of active Heymann nephritis by lα, 25 dihydroxyvitamin D3
DD Branisteanu, P Leenaerts, B Damme, R Bouillon |
Clinical & Experimental Immunology | 1993 |
Physiological Actions and Clinical Applications of Transforming Growth Factor-β (TGF-β)
AB Roberts, MB Sporn |
Growth Factors | 1993 |
Immunomodulatory role of 1,25-dihydroxyvitamin D3
JM Lemire |
Journal of Cellular Biochemistry | 1992 |
1,25-Dihydroxyvitamin D3 inhibits the passive transfer of cellular immunity by a myelin basic protein-specific T cell clone
JM Lemire, JS Adams |
Journal of Bone and Mineral Research | 1992 |
1,25-Dihydroxyvitamin D3Attenuates of Expression of Experimental Murine Lupus of MRL/1 Mice
JM Lemire, A Ince, M Takashima |
Autoimmunity | 1992 |
Potential role of prostaglandins and leukotrienes in multiple sclerosis and experimental allergic encephalomyelitis
DJ Fretland |
Prostaglandins Leukotrienes and Essential Fatty Acids | 1992 |
Vitamin neurotoxicity
SR Snodgrass |
Molecular Neurobiology | 1992 |
1,25-Dihydroxyvitamin D3 enhances the generation of nonspecific suppressor cells while inhibiting the induction of cytotoxic cells in a human MLR
MA Meehan, RH Kerman, JM Lemire |
Cellular Immunology | 1992 |
Immunological properties of vitamin D analogues and metabolites
L Binderup |
Biochemical Pharmacology | 1992 |
Vitamin D
A Portale, Β Halloran, E Lonergan, R Morris |
Vitamin D | 1988 |